Cargando…
Cost-effectiveness analysis of cardiac implantable electronic devices with reactive atrial-based antitachycardia pacing
AIMS: Reactive atrial-based anti-tachycardia pacing (rATP) in pacemakers (PMs) and cardiac resynchronization therapy defibrillators (CRT-Ds) has been reported to prevent progression of atrial fibrillation, and this reduced progression is expected to decrease the risk of complications such as stroke...
Autores principales: | Noda, Takashi, Ueda, Nobuhiko, Tanaka, Yuji, Ishiguro, Yoko, Matsumoto, Tomoko, Uenishi, Tatsuhiro, Yamaguchi, Hiroko, Shoji, Ayako, Myung, Jae-Eun, Kusano, Kengo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062312/ https://www.ncbi.nlm.nih.gov/pubmed/36691793 http://dx.doi.org/10.1093/europace/euad003 |
Ejemplares similares
-
Reactive atrial‐based antitachycardia pacing therapy reduces atrial tachyarrhythmias
por: Crossley, George H., et al.
Publicado: (2019) -
Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
por: Sumiyoshi, Hironobu, et al.
Publicado: (2023) -
Unsuccessful antitachycardia pacing: What is the mechanism?
por: Strik, Marc, et al.
Publicado: (2019) -
Atrial Antitachycardia Pacing in Complex Congenital Heart Disease: A Case Series
por: Kramer, Collin C., et al.
Publicado: (2018) -
Intrinsic antitachycardia pacing for patients with multiple ventricular tachycardias
por: Okubo, Kenji, et al.
Publicado: (2022)